Respirology year-in-review 2006: clinical science
- PMID: 17207019
- PMCID: PMC7192212
- DOI: 10.1111/j.1440-1843.2006.01004.x
Respirology year-in-review 2006: clinical science
Similar articles
-
Respirology year-in-review 2006: Basic science.Respirology. 2007 Mar;12(2):184-90. doi: 10.1111/j.1440-1843.2007.01045.x. Respirology. 2007. PMID: 17298449 Review.
-
Innovation in lung health research--a Copernican revolution?Lancet Respir Med. 2013 Sep;1(7):506-7. doi: 10.1016/S2213-2600(13)70142-5. Epub 2013 Jul 24. Lancet Respir Med. 2013. PMID: 24461604 No abstract available.
-
[50th Congress of the German Society for Pneumology and Respiratory Medicine].Pneumologie. 2009 Jul;63(7):359-62. doi: 10.1055/s-0029-1233249. Epub 2009 Jul 13. Pneumologie. 2009. PMID: 19598082 German. No abstract available.
-
40. Jahrestagung der Österreichischen Gesellschaft für Pneumologie. Wien, 6.-8. Oktober 2016.Wien Klin Wochenschr. 2016 Oct;128(19-20):751-784. doi: 10.1007/s00508-016-1103-9. Wien Klin Wochenschr. 2016. PMID: 27670859 No abstract available.
-
Update in pediatrics 2005.Am J Respir Crit Care Med. 2006 Mar 15;173(6):585-92. doi: 10.1164/rccm.2601002. Am J Respir Crit Care Med. 2006. PMID: 16522763 Review. No abstract available.
References
-
- Gabrielson E. Worldwide trends in lung cancer pathology. Respirology 2006; 11: 533–8. - PubMed
-
- Ho JC, Wong MP, Lam WK. Lymphoepithelioma‐like carcinoma of the lung. Respirology 2006; 11: 539–45. - PubMed
-
- Ahmed SM, Salgia R. Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer. Respirology 2006; 11: 687–92. - PubMed
-
- Kato T, Nishio K. Clinical aspects of epithelial growth factor receptor inhibitors: benefit and risk. Respirology 2006; 11: 693–8. - PubMed
-
- Liam CK, Pang YK, Leow CH. Epidermal growth factor receptor targeted therapy with gefitinib in locally advanced and metastatic primary lung adenocarcinoma. Respirology 2006; 11: 287–91. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical